CAS 26239-55-4 - Factory, Suppliers, Manufacturers from China

CAS 26239-55-4, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

CAS RN 26239-55-4 ADA — ADA CAS 26239-55-4 Purity >99.0% (Titration) Biological Buffer Ultra Pure Factory
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...

2022.10.24 22:09:10
2022.09.08 17:07:03
2022.08.12 12:19:38
2022.07.10 03:48:20
2022.04.15 03:02:26
2021.11.25 06:46:16

CAS 26239-55-4 - Factory, Suppliers, Manufacturers from China

Related Products

ADA CAS 26239-55-4 Purity >99.0% (Titration) Biological Buffer Ultra Pure Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

2-Iodo-4-Nitroaniline CAS 6293-83-0 Purity >98.0% (HPLC)

1-Boc-Piperazine CAS 57260-71-6 Purity >99.5% (GC) Factory

Fmoc-D-Abu-OH CAS 170642-27-0 Purity >98.0% (HPLC) Factory

Boc-Glu(OtBu)-OH CAS 13726-84-6 Purity >99.0% (HPLC) Factory

3-Bromo-2-Methylbenzoic Acid CAS 76006-33-2 Assay ≥99.0% (HPLC) Factory

L-Alaninol CAS 2749-11-3 (H-Ala-ol) Purity >99.5% (GC) Factory

2,3-Dibromothiophene CAS 3140-93-0 Purity >98.0% (GC) Factory Hot Sale

5-Iodoindole CAS 16066-91-4 Purity >99.0% (HPLC) Factory High Quality

2,4-Dimethylthiophenol CAS 13616-82-5 Purity >99.0% (GC)

Pyrroloquinoline Quinone (PQQ) CAS 72909-34-3 Purity >99.0% (HPLC) Factory

Linagliptin CAS 668270-12-0 Purity ≥99.0% (HPLC) Factory

4'-Benzyloxyacetophenone CAS 54696-05-8 Purity >99.0% (HPLC)

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Paxlovid: what we know about Pfizer's Covid-19 pill

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Yellow phosphorus and phosphoric acid rose together

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Xi presents award to top scientists

2022.10.24 22:09:10

2022.09.08 17:07:03

2022.08.12 12:19:38

2022.07.10 03:48:20

2022.04.15 03:02:26

2021.11.25 06:46:16

related search